Follow
Onur Cizmecioglu
Onur Cizmecioglu
Asst. Prof., Bilkent University
Verified email at bilkent.edu.tr
Title
Cited by
Cited by
Year
Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome
O Cizmecioglu, M Arnold, R Bahtz, F Settele, L Ehret, U Haselmann-Weiß, ...
Journal of Cell Biology 191 (4), 731-739, 2010
3322010
Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition
O Timofeev, O Cizmecioglu, F Settele, T Kempf, I Hoffmann
Journal of Biological Chemistry 285 (22), 16978-16990, 2010
2002010
PLK2 phosphorylation is critical for CPAP function in procentriole formation during the centrosome cycle
J Chang, O Cizmecioglu, I Hoffmann, K Rhee
The EMBO journal 29 (14), 2395-2406, 2010
992010
Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4)
O Cizmecioglu, A Krause, R Bahtz, L Ehret, N Malek, I Hoffmann
Journal of cell science 125 (4), 981-992, 2012
912012
Plk2 regulated centriole duplication is dependent on its localization to the centrosome and a functional polo-box domain
O Cizmecioglu, S Warnke, M Arnold, S Duensing, I Hoffmann
Cell cycle 7 (22), 3548-3555, 2008
782008
Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity
I Tumurbaatar, O Cizmecioglu, I Hoffmann, I Grummt, R Voit
PloS one 6 (2), e14711, 2011
572011
Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss
O Cizmecioglu, J Ni, S Xie, JJ Zhao, TM Roberts
Elife 5, e17635, 2016
452016
Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases
O Timofeev, O Cizmecioglu, E Hu, T Orlik, I Hoffmann
FEBS letters 583 (4), 841-847, 2009
302009
Polyoma small T antigen triggers cell death via mitotic catastrophe
AT Pores Fernando, S Andrabi, O Cizmecioglu, C Zhu, DM Livingston, ...
Oncogene 34 (19), 2483-2492, 2015
192015
Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
X Gao, Y Wang, CF Ribeiro, C Manokaran, H Chang, T Von, S Rodrigues, ...
Molecular Cancer Research 20 (5), 673-685, 2022
102022
Rafting on the plasma membrane: lipid rafts in signaling and disease
OA Isik, O Cizmecioglu
Cell Biology and Translational Medicine, Volume 20: Organ Function …, 2023
82023
ZAP70 activation compensates for loss of Class IA PI3K Isoforms through activation of the JAK–STAT3 pathway
M Demir, O Cizmecioglu
Cancer Diagnosis & Prognosis 2 (3), 391, 2022
82022
Cholesterol biogenesis is a PTEN‐dependent actionable node for the treatment of endocrine therapy‐refractory cancers
I Kaysudu, TB Gungul, S Atici, S Yilmaz, E Bayram, G Guven, ...
Cancer Science 114 (11), 4365-4375, 2023
32023
p110alpha activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle
O Çizmecioğlu
Turkish Journal of Biology 46 (3), 207-215, 2022
12022
Kizuna takes pole position
O Cizmecioglu, I Hoffmann
Nature Cell Biology 8 (10), 1050-1051, 2006
12006
PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer
S Yilmaz, O Cizmecioglu
2024
Molecular mechanisms of PI3K isoform dependence in embryonic growth
S Atıcı, O Çizmecioğlu
Journal of the Turkish German Gynecological Association 25 (3), 159, 2024
2024
Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt
HB Catalak Yilmaz, M Sulaiman, OA Isik, O Cizmecioglu
Turkish Journal of Biochemistry 49 (2), 210-219, 2024
2024
RNA related publications
A Postepska-Igielska, I Grummt, W Xie, T Ling, Y Zhou, W Feng, Q Zhu, ...
Cell Host Microbe 12, 71-85, 2012
2012
Cep152 and Plk4 form a double act
B Short
Journal of Cell Biology 191 (4), 695-695, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20